Rinat Neuroscience Corporation

Rinat Neuroscience Corp. is a privately held biotechnology company dedicated to the discovery, manufacture and marketing of novel medicines to treat neurological diseases. The company is applying state-of-the-art genetic, genomic and cell biology technologies as well as innovative science to understand brain function and to develop a unified drug discovery platform for multiple brain disorders. Armed with this discovery platform, Rinat intends to become a leading supplier of novel therapeutic agents to treat major neurological disorders including neuropathy and pain.

Contact Details: 3155 Porter Drive Palo Alto CA 94304 United States of America Tel: (650) 813 9250 Fax: (650) 813 9268 Email: patrick@rinatneuro.com WWW: www.rinatneuro.com/

Loading...

Recent Publications by Rinat Neuroscience Corporation:
Regulatory issues in aging pharmacology. Many current drugs increase the average lifespan by preventing fatal...	19th April, 2006	Rinat Neuroscience Corporation, South San Francisco, California 94080,	Aging Cell. 2006 Feb;5(1):3-8. DOI Direct Link
Novel class of pain drugs based on antagonism of NGF. Nerve growth factor (NGF) was identified originally as a survival factor...	6th April, 2006	Rinat Neuroscience Corporation, 230 East Grand Avenue, South San	Trends Pharmacol Sci. 2006 Feb;27(2):85-91. Epub 2005 Dec 27. DOI Direct Link
Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain and cachexia are two of the most debilitating aspects of rheumatoid...	1st September, 2005	Rinat Neuroscience Corp., 3155 Porter Drive, Palo Alto, CA 94304, USA.	Pain. 2005 Jul;116(1-2):8-16. DOI Direct Link
Molecular basis for catecholaminergic neuron diversity. Catecholaminergic neurons control diverse cognitive, motor, and endocrine...	16th December, 2004	Rinat Neuroscience, 3155 Porter Drive, Palo Alto, CA 94304, USA.	Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13891-6. Epub 2004 Sep 7. DOI Direct Link
Molecular mechanisms controlling the development of dopaminergic neurons. Dopaminergic (DA) neurons in the midbrain are critically involved in...	27th February, 2004	Rinat Neuroscience	Semin Cell Dev Biol. 2003 Jun;14(3):175-80.
→View more Rinat Neuroscience Corporation research publications.

BioNews Results for Rinat Neuroscience Corporation:
Nektar Squeezes Good Sublease Deal from Pfizer	GlobeSt.com:  Oct 6 2009 9:17PM Matching: rinat neuroscience
Nektar Subleases 102,000-SF Pfizer R&D	GlobeSt.com:  Oct 5 2009 3:31PM Matching: rinat neuroscience
Franz Hefti and Ulrich Feige join CovagenEURs Scientific Advisory Board	Pharma Live:  Aug 20 2009 1:49PM Matching: rinat neuroscience

Rinat Neuroscience Corporation Patents:
US Patent No.	Title
7425329	Methods for treating bone cancer pain by administering a nerve growth factor antagonist
7255860	Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody
7252822	Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 3257 times since April 2007, the link to the organisation's website has been followed 664 times

Recent Search Terms used to find this page: Rinat Biotechnology | rinat neuron | rinat neuroscience 2009 | rinat neuroscience corporation | Rinat Neuroscience Corp. | RINAT NEUROSCIENCE CORP WEBSITE | Rinat Neuroscience Corp | Rinat Neuroscience | Rinat Neuroscience Corp | rinat computation scientific | .

Search for more companies in Palo Alto

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Rinat Neuroscience Corporation